Rui Hu

1.2k total citations
45 papers, 889 citations indexed

About

Rui Hu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Rui Hu has authored 45 papers receiving a total of 889 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 16 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Rui Hu's work include Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (7 papers) and Ferroptosis and cancer prognosis (6 papers). Rui Hu is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (7 papers) and Ferroptosis and cancer prognosis (6 papers). Rui Hu collaborates with scholars based in China, Macao and United States. Rui Hu's co-authors include Haibo Xiao, Zheyi Chen, Yingxia Zheng, Shiyu Chen, Bingqian Zhou, Lisong Shen, Guohua Xie, Junyao Yang, Yanhui Ma and Han Li and has published in prestigious journals such as Nature Communications, PLoS ONE and Scientific Reports.

In The Last Decade

Rui Hu

39 papers receiving 884 citations

Peers

Rui Hu
Jue Yang China
Jiateng Zhong China
Lesley A. Stark United Kingdom
Danupon Nantajit United States
Rachel Slottke United States
Dengbo Ji China
Yu Zeng China
Qian Yan China
Roberta Venè Italy
Emma E. Ramsay Australia
Jue Yang China
Rui Hu
Citations per year, relative to Rui Hu Rui Hu (= 1×) peers Jue Yang

Countries citing papers authored by Rui Hu

Since Specialization
Citations

This map shows the geographic impact of Rui Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Hu more than expected).

Fields of papers citing papers by Rui Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Hu. The network helps show where Rui Hu may publish in the future.

Co-authorship network of co-authors of Rui Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Rui Hu. A scholar is included among the top collaborators of Rui Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui Hu. Rui Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Bi, Rui, et al.. (2024). Butyrate attenuates the stemness of lung cancer cells through lysosome Fe2+- and SLC7A11-mediated ferroptosis. Heliyon. 10(7). e28093–e28093. 4 indexed citations
4.
Sun, Jialing, Mengqing Ma, Xin Zhong, et al.. (2024). Investigating the molecular mechanism of Qizhu anticancer prescription in inhibiting hepatocellular carcinoma based on high-resolution mass spectrometry and network pharmacology. Journal of Ethnopharmacology. 328. 117985–117985. 4 indexed citations
5.
Huang, Qi, Xin Zhong, Jing Li, et al.. (2024). Exosomal ncRNAs: Multifunctional contributors to the immunosuppressive tumor microenvironment of hepatocellular carcinoma. Biomedicine & Pharmacotherapy. 173. 116409–116409. 7 indexed citations
6.
Huang, Qi, Wenfeng Ma, Jialing Sun, et al.. (2023). Role of liensinine in sensitivity of activated macrophages to ferroptosis and in acute liver injury. Cell Death Discovery. 9(1). 189–189. 13 indexed citations
7.
Li, Jing, Qi Huang, Rui Hu, et al.. (2023). FAT4 expression in peripheral blood mononuclear cells is associated with prognosis and immune cell infiltration in hepatocellular carcinoma. Scientific Reports. 13(1). 15735–15735. 2 indexed citations
8.
9.
Hu, Rui, Bingqian Zhou, Zheyi Chen, et al.. (2022). PRMT5 Inhibition Promotes PD-L1 Expression and Immuno-Resistance in Lung Cancer. Frontiers in Immunology. 12. 722188–722188. 35 indexed citations
10.
Zheng, Yingxia, Han Li, Zheyi Chen, et al.. (2022). PD-L1+CD8+ T cells enrichment in lung cancer exerted regulatory function and tumor-promoting tolerance. iScience. 25(2). 103785–103785. 27 indexed citations
11.
Du, Wei, Yuhan Jiang, Rui Hu, et al.. (2022). Iron deposition heterogeneity in extrapyramidal system assessed by quantitative susceptibility mapping in Parkinson’s disease patients with type 2 diabetes mellitus. Frontiers in Aging Neuroscience. 14. 975390–975390. 4 indexed citations
12.
Cui, Pin, Wenfeng Ma, Zhiyi Han, et al.. (2022). Detection and monitoring of HBV-related hepatocellular carcinoma from plasma cfDNA fragmentation profiles. Genomics. 114(6). 110502–110502. 7 indexed citations
13.
Hu, Rui, Qi Wang, Yanfei Jia, et al.. (2021). Hypoxia-induced DEC1 mediates trophoblast cell proliferation and migration via HIF1α signaling pathway. Tissue and Cell. 73. 101616–101616. 8 indexed citations
14.
15.
Hu, Rui, Rui Bi, Lianyong Jiang, et al.. (2021). LncRNA RP11-465B22.8 triggers esophageal cancer progression by targeting miR-765/KLK4 axis. Cell Death Discovery. 7(1). 262–262. 18 indexed citations
16.
Liu, Hao, et al.. (2020). Novel coumarin-thiazolyl ester derivatives as potential DNA gyrase Inhibitors: Design, synthesis, and antibacterial activity. Bioorganic Chemistry. 100. 103907–103907. 42 indexed citations
17.
Zheng, Yingxia, Zheyi Chen, Yichao Han, et al.. (2020). Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment. Nature Communications. 11(1). 6268–6268. 282 indexed citations
18.
Sun, Xiaohui, Xu Tang, Rui Hu, et al.. (2019). Biosynthetic bifunctional enzyme complex with high-efficiency luciferin-recycling to enhance the bioluminescence imaging. International Journal of Biological Macromolecules. 130. 705–714. 5 indexed citations
19.
Hu, Wei, et al.. (2015). Studies on the purification of polypeptide from sika antler plate and activities of antitumor. BMC Complementary and Alternative Medicine. 15(1). 328–328. 19 indexed citations
20.
Jia, Yanfei, Dongjie Xiao, Xiaoli Ma, et al.. (2013). Differentiated embryonic chondrocyte-expressed gene 1 is associated with hypoxia-inducible factor 1α and Ki67 in human gastric cancer. Diagnostic Pathology. 8(1). 37–37. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jue Yang Breakdown of academic impact, for papers by Jiateng Zhong Breakdown of academic impact, for papers by Lesley A. Stark Breakdown of academic impact, for papers by Danupon Nantajit Breakdown of academic impact, for papers by Rachel Slottke Breakdown of academic impact, for papers by Dengbo Ji Breakdown of academic impact, for papers by Yu Zeng Breakdown of academic impact, for papers by Qian Yan Breakdown of academic impact, for papers by Roberta Venè Breakdown of academic impact, for papers by Emma E. Ramsay
Rankless by CCL
2026